Assessing disease activity in Crohn's disease - Are we there yet?

Rami Eliakim, Daniel Rachmilewitz*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review


Many attempts have been made over recent years to assess accurately disease activity in Crohn's disease. We review some of these attempts, giving particular emphasis to the combination of serum levels of proinflammatory cytokines (interleukin-6, tumour necrosis factor α, recombinant interleukin-2 and acid α-1-glycoprotein).

Original languageEnglish
Pages (from-to)929-930
Number of pages2
JournalEuropean Journal of Gastroenterology and Hepatology
Issue number10
StatePublished - 1997
Externally publishedYes


  • Acid α-1-glycoprotein
  • Crohn's disease
  • Interleukin-6
  • Recombinant interleukin-2
  • Tumour necrosis factor α


Dive into the research topics of 'Assessing disease activity in Crohn's disease - Are we there yet?'. Together they form a unique fingerprint.

Cite this